Transdiagnostic treatment of emotional disorders for women with multiple sclerosis: a randomized controlled trial
Authors:
Open Access
- 31 October 2020
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 20 (1) , 1-11
Abstract
Background: Multiple sclerosis (MS) is a chronic, unpredictable, neurodegenerative disease, significantly associated with psychological, behavioral, cognitive, and emotional consequences. MS is more common in females than males and frequently affects women during their reproductive years. Despite the frequent mental disorders, comorbidities, and emotional problems in People with MS (PwMS), these conditions are too often underdiagnosed and undertreated. Objective: This study aimed to examine the efficacy of a group format of the Unified Protocol (UP) for the Transdiagnostic treatment of depression and anxiety disorders in females with MS. Methods: In the present study, Sixty-four adult females diagnosed with MS were randomized to either the UP (n = 32) or treatment-as-usual conditions. The assessment protocol included semi-structured clinical interviews and self-reports evaluating diagnostic criteria, depression, anxiety and worry symptoms, emotional regulation, and affectivity. Results: Repeated measure analysis of variance (ANOVA) revealed that the UP significantly improved depression scores [Cohen’s d = − 2.11, 95% CI (− 2.72, − 1.50)], anxiety scores [Cohen’s d = − 3.34, 95% CI (− 4.01, − 2.58)], positive and negative affect scale (PANAS)-positive affect scores [Cohen’s d = 1.46, 95% CI (1.46, 2.01)], PANAS-negative affect scores [Coen’s d = − 2.21, 95% CI (− 2.84, − 1.60)], difficulties emotion regulation scale scores [Cohen’s d = 1.40, 95% CI (− 0.87, − 0.03)], and Worry scale scores [Cohen’s d = − 0.45, 95% CI (− 0.95, − 0.04)] at the end of treatment relative to compared to the control condition. Also, treatment gains were maintained at the three-month follow-up (p < 0.001). Conclusion: The findings provide the support that the UP could be an additional efficient psychological treatment for females with MS. ISRCTN Number: ISRCTN95459505.Keywords
This publication has 73 references indexed in Scilit:
- The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease SeverityPLOS ONE, 2013
- Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric PopulationsISRN Neurology, 2012
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- A review of psychological correlates of adjustment in patients with multiple sclerosisClinical Psychology Review, 2009
- A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: Implications for assessment and treatment.Psychological Assessment, 2009
- Emotional Expression and the Decision to Seek Therapy: The Mediating Roles of the Anticipated Benefits and RisksJournal of Social and Clinical Psychology, 2008
- Suicide among Danes with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Toward a unified treatment for emotional disordersBehavior Therapy, 2004
- Personality similarity in twins reared apart and together.Journal of Personality and Social Psychology, 1988
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983